Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Thall

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Bailliere'S Clinical Haematology|June 1, 1997
Cytogenetics of chronic myelogenous leukaemiaS O'Brien, P F Thall, M J Siciliano
Blood|December 23, 1999
Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEBE H Estey, Y Shen, P F Thall
Biometrics|April 28, 2000
Approximate Bayesian evaluation of multiple treatment effectsP F Thall, R M Simon, Y Shen
Biometrics|June 1, 1989
A two-stage design for choosing among several experimental treatments and a control in clinical trialsP F Thall, R Simon, S S Ellenberg
Statistics in Medicine|May 3, 2000
Evaluating multiple treatment courses in clinical trialsP F Thall, R E Millikan, H G Sung
Bone Marrow Transplantation|May 4, 2004
Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effectsP F Thall, R E Champlin, B S Andersson
Investigational New Drugs|January 19, 2000
A new statistical method for dose-finding based on efficacy and toxicity in early phase clinical trialsP F Thall, E H Estey, H G Sung
Statistics in Medicine|February 28, 1995
Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomesP F Thall, R M Simon, E H Estey
Anesthesiology|February 7, 2001
Maximum tolerated dose of nalmefene in patients receiving epidural fentanyl and dilute bupivacaine for postoperative analgesiaT B Dougherty, V H Porche, P F Thall
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
New statistical strategy for monitoring safety and efficacy in single-arm clinical trialsP F Thall, R M Simon, E H Estey
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Bailliere'S Clinical Haematology|June 1, 1997
Cytogenetics of chronic myelogenous leukaemiaS O'Brien, P F Thall, M J Siciliano
Blood|December 23, 1999
Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEBE H Estey, Y Shen, P F Thall
Biometrics|April 28, 2000
Approximate Bayesian evaluation of multiple treatment effectsP F Thall, R M Simon, Y Shen
Biometrics|June 1, 1989
A two-stage design for choosing among several experimental treatments and a control in clinical trialsP F Thall, R Simon, S S Ellenberg
Statistics in Medicine|May 3, 2000
Evaluating multiple treatment courses in clinical trialsP F Thall, R E Millikan, H G Sung
Bone Marrow Transplantation|May 4, 2004
Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effectsP F Thall, R E Champlin, B S Andersson
Investigational New Drugs|January 19, 2000
A new statistical method for dose-finding based on efficacy and toxicity in early phase clinical trialsP F Thall, E H Estey, H G Sung
Statistics in Medicine|February 28, 1995
Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomesP F Thall, R M Simon, E H Estey
Anesthesiology|February 7, 2001
Maximum tolerated dose of nalmefene in patients receiving epidural fentanyl and dilute bupivacaine for postoperative analgesiaT B Dougherty, V H Porche, P F Thall
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
New statistical strategy for monitoring safety and efficacy in single-arm clinical trialsP F Thall, R M Simon, E H Estey
Pageof 6